CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Clinical trial NCT00090896 · COMPLETED

Trial details

NCT number: NCT00090896
Sponsor: Jonsson Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2004-04-01
Primary completion: 2008-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.